← All Plus Therapeutics, INC filings

Plus Therapeutics, INC Form 4 insider transactions

NASDAQ
PSTV
Plus Therapeutics, INC
Form 4: Plus Therapeutics Director Greg Petersen Reports Securities Transactions
Director Greg Petersen of Plus Therapeutics reports the acquisition and disposal of common stock and warrants.
NASDAQ
PSTV
Plus Therapeutics, INC
Form 4: Plus Therapeutics Director Clowes Acquires Shares and Warrants
Director Howard Clowes reports acquisition of Plus Therapeutics common stock and warrants.
NASDAQ
PSTV
Plus Therapeutics, INC
Form 4: Plus Therapeutics Director Acquires Shares and Warrants
Director Richard J. Hawkins reports acquisition of Plus Therapeutics common stock and warrants.
NASDAQ
PSTV
Plus Therapeutics, INC
Form 4: Plus Therapeutics Director Lenk Reports Transaction in Company Stock
Director Robert P. Lenk reports acquisition and disposal of Plus Therapeutics (PSTV) common stock and warrants on May 8, 2024.